跳至主要内容
临床试验/NCT05590715
NCT05590715招募中不适用

International, Multicentric, Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Stalicla SA21 个研究点 分布在 3 个国家目标入组 1,500 人开始时间: 2022年10月13日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Stalicla SA
入组人数
1,500
试验地点
21
主要终点
Clinical characterisation of the ASD-Phen1 and ASD-Phen2 subpopulations.

研究概览

简要总结

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
12 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants previously diagnosed with ASD (DSM-5)
  • Available well-documented health records within the first 2 years of life
  • Participants must have a parent or reliable caregiver who agrees to provide information about the participant
  • Participants willing and consenting or assenting to participate.

排除标准

  • Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment.
  • If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.

结局指标

主要结局

Clinical characterisation of the ASD-Phen1 and ASD-Phen2 subpopulations.

时间窗: Day 0

A semi-structured medical questionnaire will be administered to collect clinical (sign and symptoms) and anthropomorphic features.

Molecular characterization of the ASD-Phen1 and ASD-Phen2 subpopulations

时间窗: Day 0

Better characterize subpopulations of ASD subjects and potentially identify/confirm a molecular signature specific of each subpopulation.

次要结局

未报告次要终点

研究者

发起方
Stalicla SA
申办方类型
Industry
责任方
Sponsor

研究点 (21)

Loading locations...

相似试验